Corbus Pharmaceuticals Holdings, Inc.

CRBP · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$26,983$20,044$18,900$17,198
Short-Term Investments$0$96,548$113,887$131,864
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$80,588$6,233$4,573$3,914
Total Curr. Assets$107,571$122,825$137,360$152,976
Property Plant & Equip (Net)$1,558$1,875$2,186$2,518
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$385$385$385$385
Total NC Assets$1,943$2,260$2,571$2,903
Other Assets$0$0$0$0
Total Assets$109,514$125,085$139,931$155,879
Liabilities
Payables$2,740$3,988$4,068$4,786
Short-Term Debt$1,742$1,695$1,650$1,606
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$12,578$7,650$5,902$5,426
Total Curr. Liab.$17,060$13,333$11,620$11,818
LT Debt$307$761$1,205$1,633
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$307$761$1,205$1,633
Other Liabilities$0$0$0$0
Cap. Leases$0$2,456$2,855$3,239
Total Liabilities$17,367$14,094$12,825$13,451
Equity
Pref Stock$0$0$0$0
Common Stock$1$1$1$1
Retained Earnings-$534,875-$511,533-$493,871-$476,893
AOCI-$3-$39-$23$35
Other Equity$627,024$622,562$620,999$619,285
Total Equity$92,147$110,991$127,106$142,428
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$109,514$125,085$139,931$155,879
Net Debt-$24,934-$17,588-$16,045-$13,959